$SGEN News Article - PADCEV (enfortumab vedotin-e
Post# of 74
(Total Views: 118)
Posted On: 09/22/2023 10:50:51 AM
$SGEN News Article - PADCEV (enfortumab vedotin-ejfv) and KEYTRUDA (pembrolizumab) Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer in Pivotal Phase 3 EV-302 Trial https://marketwirenews.com/news-releases/padc...65437.html
(0)
(0)Seattle Genetics Inc. (SGEN) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼